Latest SR ONE CAPITAL MANAGEMENT, LP Stock Portfolio
SR ONE CAPITAL MANAGEMENT, LP Performance:
2024 Q3: 28.53%YTD: 24.53%2023: 29.69%
Performance for 2024 Q3 is 28.53%, and YTD is 24.53%, and 2023 is 29.69%.
About SR ONE CAPITAL MANAGEMENT, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, SR One Capital Management, LP reported an equity portfolio of $498.7 Millions as of 30 Sep, 2024.
The top stock holdings of SR One Capital Management, LP are ACLX, , SBTX. The fund has invested 39.3% of it's portfolio in ARCELLX, INC. and 16.7% of portfolio in ZENAS BIOPHARMA, INC.
SR One Capital Management, LP opened new stock positions in ZENAS BIOPHARMA, INC. The fund showed a lot of confidence in some stocks as they added substantially to ENGENE HOLDINGS INC..
The top stock holdings of SR One Capital Management, LP are ACLX, , SBTX. The fund has invested 39.3% of it's portfolio in ARCELLX, INC. and 16.7% of portfolio in ZENAS BIOPHARMA, INC.
SR One Capital Management, LP opened new stock positions in ZENAS BIOPHARMA, INC. The fund showed a lot of confidence in some stocks as they added substantially to ENGENE HOLDINGS INC..
SR ONE CAPITAL MANAGEMENT, LP Annual Return Estimates Vs S&P 500
Our best estimate is that SR One Capital Management, LP made a return of 28.53% in the last quarter. In trailing 12 months, it's portfolio return was 78.47%.
New Buys
| Ticker | $ Bought |
|---|---|
| zenas biopharma, inc | 83,103,200 |
| oruka therapeutics, inc | 9,199,340 |
New stocks bought by SR ONE CAPITAL MANAGEMENT, LP
Additions
| Ticker | % Inc. |
|---|---|
| engene holdings inc. | 49.55 |
Additions to existing portfolio by SR ONE CAPITAL MANAGEMENT, LP
Reductions
Sold off
Sector Distribution
SR One Capital Management, LP has about 59.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 59.7 |
| Others | 28.6 |
| 11.7 |
Market Cap. Distribution
SR One Capital Management, LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 49.2 |
| UNALLOCATED | 28.6 |
| SMALL-CAP | 14.7 |
| MICRO-CAP | 7 |
Stocks belong to which Index?
About 49.4% of the stocks held by SR One Capital Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 50.6 |
| RUSSELL 2000 | 49.4 |
SR ONE CAPITAL MANAGEMENT, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SR ONE CAPITAL MANAGEMENT, LP
SR One Capital Management, LP has 11 stocks in it's portfolio. CRSP proved to be the most loss making stock for the portfolio. ACLX was the most profitable stock for SR One Capital Management, LP last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx, inc. | 39.29 | 2,346,630 | 195,967,000 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 9.88 | 1,048,950 | 49,279,700 | unchanged | 0.00 | ||
| DSGN | design therapeutics, inc. | 7.04 | 6,526,480 | 35,112,400 | unchanged | 0.00 | ||
| KALA | kala bio, inc. | 0.51 | 443,661 | 2,528,870 | unchanged | 0.00 | ||
| NKTX | nkarta, inc. | 3.02 | 3,333,330 | 15,066,700 | unchanged | 0.00 | ||
| SBTX | ars pharmaceuticals, inc. | 11.67 | 4,012,900 | 58,187,100 | unchanged | 0.00 | ||
| zenas biopharma, inc | 16.66 | 4,911,540 | 83,103,200 | new | ||||
| mineralys therapeutics inc. | 4.90 | 2,016,820 | 24,423,700 | unchanged | 0.00 | |||
| alumis inc. | 4.20 | 1,959,900 | 20,931,700 | unchanged | 0.00 | |||
| oruka therapeutics, inc | 1.84 | 375,330 | 9,199,340 | new | ||||
| engene holdings inc. | 0.99 | 747,750 | 4,935,150 | added | 49.55 | |||